Market Overview

Herbalife Issues Response to Misleading, Inaccurate Info

Related HLF
Dietary Supplement Stocks Getting Killed By DoJ, FDA's Forthcoming Press Conference
Keep an Eye on These 10 Stocks for November 4, 2015

Herbalife (NYSE: HLF) today issued the following statement following misleading and inaccurate information in the marketplace this morning:

Other than the voluntary dialogue with regulators, which we communicated on our January investor day, we are unaware of any other regulatory interest and/or investigation. We are demanding a correction from the NY Post.

Since its founding in 1980, Herbalife has positively impacted the lives and health of consumers. For a direct selling company of our size, we have had a relatively low number of complaints to the FTC. However, we take every one of them seriously and stand by our record of doing right by our distributors and all consumers of our products.

Posted-In: News


Related Articles (HLF)

View Comments and Join the Discussion!

Get Benzinga's Newsletters